Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 2013989, 9 pages
https://doi.org/10.1155/2017/2013989
Research Article

The Combination of the Tumor Markers Suggests the Histological Diagnosis of Lung Cancer

1Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266003, China
2Department of Critical Care Medicine, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao 266003, China
3Department of Microbiology, Weifang Medical University, Weifang, Shandong 261053, China

Correspondence should be addressed to Mingjun Liu; moc.liamtoh@jmlkcoj

Received 6 January 2017; Revised 28 March 2017; Accepted 24 April 2017; Published 18 May 2017

Academic Editor: Noriyoshi Sawabata

Copyright © 2017 Linjie Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [6 citations]

The following is the list of published articles that have cited the current article.

  • Chia-Tzu Kuo, Nan-Fu Chiu, and Ting-Li Lin, “Highly sensitive carboxyl-graphene oxide-based surface plasmon resonance immunosensor for the detection of lung cancer for cytokeratin 19 biomarker in human plasma,” Sensors and Actuators, B: Chemical, vol. 265, pp. 264–272, 2018. View at Publisher · View at Google Scholar
  • Yuquan Bai, Wulin Shen, Xuefeng Zhou, Hexiao Tang, Yanhong Wei, Ming Xu, and Jinping Zhao, “Clinical significance of combined detection of interleukin-6 and tumour markers in lung cancer,” Autoimmunity, vol. 51, no. 4, pp. 191–198, 2018. View at Publisher · View at Google Scholar
  • Elif Tugce Korkmaz, Deniz Koksal, Funda Aksu, Z. Gunnur Dikmen, Duygu İcen, Emin Maden, Sevgen Onder, Filiz Akbiyik, and Salih Emri, “Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer,” Clinical Biochemistry, 2018. View at Publisher · View at Google Scholar
  • Qixian Yang, Ping Zhang, Rongqiang Wu, Kefeng Lu, and Hongxing Zhou, “Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?,” Disease Markers, vol. 2018, pp. 1–12, 2018. View at Publisher · View at Google Scholar
  • Vandana Mohan, and Ashwani Koul, “Anticancer potential of Tinospora cordifolia and arabinogalactan against benzo(a)pyrene induced pulmonary tumorigenesis: a study in relevance to various biomarkers,” Journal of Herbmed Pharmacology, vol. 7, no. 4, pp. 225–235, 2018. View at Publisher · View at Google Scholar
  • Yulin Yuan, Yanhui Zhu, Xiafang Yang, Qiuwei Lu, Xiaoxu Lu, and Huayi Huang, “Age and gender-specific reference intervals for ProGRP in healthy Chinese han ethnic adults using the roche cobas immunoassay,” Clinical Laboratory, vol. 64, no. 6, pp. 923–928, 2018. View at Publisher · View at Google Scholar